Tumor-Treating Fields Therapy for Pediatric Brain Tumors.

Area of Science:

• Neuro-oncology
• Biophysics
• Medical Engineering

Background:

• Tumor-treating fields (TTFields) are an established therapy for adult supratentorial glioblastoma (GBM).
• The safety and efficacy of TTFields in pediatric GBM are not yet confirmed.
• Pediatric GBM shares clinical behaviors with adult GBM, suggesting potential applicability.

Purpose of the Study:

• To plan an investigator-initiated clinical trial for pediatric supratentorial GBM.
• To evaluate the safety and exploratory efficacy of TTFields in pediatric GBM.
• To expand regulatory approval for TTFields in pediatric GBM treatment.

Main Methods:

• Leveraging accumulated evidence from adult GBM studies.
• Designing a clinical trial targeting pediatric supratentorial GBM.
• Combining safety and exploratory efficacy data for regulatory submission.

Main Results:

• Ongoing pediatric case series and feasibility studies indicate potential.
• Pediatric GBM heterogeneity presents challenges for efficacy confirmation.
• This planned trial aims to provide crucial data for pediatric application.

Conclusions:

• TTFields therapy warrants investigation in pediatric supratentorial GBM.
• A dedicated clinical trial is necessary to establish safety and efficacy in children.
• Successful trial outcomes could lead to expanded regulatory approval for pediatric GBM.